Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1060

1.

"I'm not doing that." An in-depth examination of nonparticipation in mail-out bowel cancer screening programs.

Goodwin BC, March S, Crawford-Williams F, Chambers SK, Dunn J.

Transl Behav Med. 2019 Jun 22. pii: ibz096. doi: 10.1093/tbm/ibz096. [Epub ahead of print]

PMID:
31228202
2.

The burden of Legionnaires' disease in New Zealand (LegiNZ): a national surveillance study.

Priest PC, Slow S, Chambers ST, Cameron CM, Balm MN, Beale MW, Blackmore TK, Burns AD, Drinković D, Elvy JA, Everts RJ, Hammer DA, Huggan PJ, Mansell CJ, Raeder VM, Roberts SA, Robinson MC, Sathyendran V, Taylor SL, Thompson AW, Ussher JE, van der Linden AJ, Williams MJ, Podmore RG, Anderson TP, Barratt K, Mitchell JL, Harte DJ, Hope VT, Murdoch DR.

Lancet Infect Dis. 2019 Jun 10. pii: S1473-3099(19)30113-6. doi: 10.1016/S1473-3099(19)30113-6. [Epub ahead of print]

PMID:
31196812
3.

Corrigendum: TCF3 alternative splicing controlled by hnRNP H/F regulates E-cadherin expression and hESC pluripotency.

Yamazaki T, Liu L, Lazarev D, Al-Zain A, Fomin V, Yeung PL, Chambers SM, Lu CW, Studer L, Manley JL.

Genes Dev. 2019 Jun 1;33(11-12):733-736. doi: 10.1101/gad.326983.119. No abstract available.

4.

Lipid Deprivation Induces a Stable, Naive-to-Primed Intermediate State of Pluripotency in Human PSCs.

Cornacchia D, Zhang C, Zimmer B, Chung SY, Fan Y, Soliman MA, Tchieu J, Chambers SM, Shah H, Paull D, Konrad C, Vincendeau M, Noggle SA, Manfredi G, Finley LWS, Cross JR, Betel D, Studer L.

Cell Stem Cell. 2019 May 21. pii: S1934-5909(19)30205-X. doi: 10.1016/j.stem.2019.05.001. [Epub ahead of print]

PMID:
31155483
5.

Synthesis of Hydrazone Derivatives of 4-[4-Formyl-3-(2-oxochromen-3-yl)pyrazol-1-yl]benzoic acid as Potent Growth Inhibitors of Antibiotic-resistant Staphylococcus aureus and Acinetobacter baumannii.

Whitt J, Duke C, Sumlin A, Chambers SA, Alnufaie R, Gilmore D, Fite T, Basnakian AG, Alam MA.

Molecules. 2019 May 29;24(11). pii: E2051. doi: 10.3390/molecules24112051.

6.

Search for an Optimal Design of a Bioprosthetic Venous Valve: In silico and in vitro Studies.

Chen HY, Tien WS, Chambers SD, Dabiri D, Kassab GS.

Eur J Vasc Endovasc Surg. 2019 May 24. pii: S1078-5884(18)30890-6. doi: 10.1016/j.ejvs.2018.12.008. [Epub ahead of print]

PMID:
31133446
7.

The importance of staying connected: Mediating and moderating effects of social group memberships on psychological well-being after brain tumor.

Cubis L, Ownsworth T, Pinkham MB, Foote M, Legg M, Chambers S.

Psychooncology. 2019 May 21. doi: 10.1002/pon.5125. [Epub ahead of print]

PMID:
31115102
8.

Novel Swine Model of Colonic Diverticulosis.

Guo X, Patel B, Han L, Al-Dulaimi H, Van Alstine WG, Noblet JN, Chambers S, Kassab GS.

Am J Physiol Gastrointest Liver Physiol. 2019 May 15. doi: 10.1152/ajpgi.00408.2018. [Epub ahead of print]

PMID:
31091148
9.

Geographic variations in stage at diagnosis and survival for colorectal cancer in Australia: A systematic review.

Crawford-Williams F, March S, Goodwin BC, Ireland MJ, Chambers SK, Aitken JF, Dunn J.

Eur J Cancer Care (Engl). 2019 May;28(3):e13072. doi: 10.1111/ecc.13072. Epub 2019 May 5. Review.

PMID:
31056787
10.

Surgical attitudes toward preoperative breast magnetic resonance imaging in women with early-stage breast cancer.

Mukherjee SD, Hodgson N, Lovrics PJ, Dhamanaskar K, Chambers S, Sussman J.

Curr Oncol. 2019 Apr;26(2):e194-e201. doi: 10.3747/co.26.4227. Epub 2019 Apr 1.

11.

Alcohol use and breast cancer risk: A qualitative study of women's perspectives to inform the development of a preventative intervention in breast clinics.

Chambers SE, Copson ER, Dutey-Magni PF, Priest C, Anderson AS, Sinclair JMA.

Eur J Cancer Care (Engl). 2019 Apr 30:e13075. doi: 10.1111/ecc.13075. [Epub ahead of print]

PMID:
31038252
12.

Geographical Variations in Prostate Cancer Outcomes: A Systematic Review of International Evidence.

Dasgupta P, Baade PD, Aitken JF, Ralph N, Chambers SK, Dunn J.

Front Oncol. 2019 Apr 8;9:238. doi: 10.3389/fonc.2019.00238. eCollection 2019.

13.

Tuning Photovoltaic Performance of Perovskite Nickelates Heterostructures by Changing the A-Site Rare-Earth Element.

Chang L, Wang L, You L, Yang Z, Abdelsamie A, Zhang Q, Zhou Y, Gu L, Chambers SA, Wang J.

ACS Appl Mater Interfaces. 2019 May 1;11(17):16191-16197. doi: 10.1021/acsami.9b01851. Epub 2019 Apr 19.

PMID:
30964625
14.

Physical activity counselling and referrals by general practitioners for prostate cancer survivors in Australia.

Barnes K, Ball L, Galvão DA, Newton RU, Chambers SK, Harrison C.

Aust J Prim Health. 2019 Apr;25(2):152-156. doi: 10.1071/PY18131.

PMID:
30955507
15.

Intracochlear tPA infusion may reduce fibrosis caused by cochlear implantation surgery.

Choong JK, Lo J, Chambers SA, Hampson AJ, Eastwood HT, O'Leary SJ.

Acta Otolaryngol. 2019 May;139(5):396-402. doi: 10.1080/00016489.2019.1587504. Epub 2019 Apr 5.

PMID:
30950671
16.

Commercial determinants of health: advertising of alcohol and unhealthy foods during sporting events.

Ireland R, Bunn C, Reith G, Philpott M, Capewell S, Boyland E, Chambers S.

Bull World Health Organ. 2019 Apr 1;97(4):290-295. doi: 10.2471/BLT.18.220087. Epub 2019 Feb 25.

17.

Exploring the relationship between Big Food corporations and professional sports clubs: a scoping review.

Ireland R, Chambers S, Bunn C.

Public Health Nutr. 2019 Jul;22(10):1888-1897. doi: 10.1017/S1368980019000545. Epub 2019 Apr 2.

PMID:
30935432
18.

Radon-based atmospheric stability classification in contrasting sub-Alpine and sub-Mediterranean environments.

Kikaj D, Chambers SD, Vaupotič J.

J Environ Radioact. 2019 Jul;203:125-134. doi: 10.1016/j.jenvrad.2019.03.010. Epub 2019 Mar 19.

PMID:
30901740
19.

Work after prostate cancer: a systematic review.

McLennan V, Ludvik D, Chambers S, Frydenberg M.

J Cancer Surviv. 2019 Apr;13(2):282-291. doi: 10.1007/s11764-019-00750-4. Epub 2019 Mar 21. Review.

PMID:
30900159
20.

The crisis of democracy and the science of deliberation.

Dryzek JS, Bächtiger A, Chambers S, Cohen J, Druckman JN, Felicetti A, Fishkin JS, Farrell DM, Fung A, Gutmann A, Landemore H, Mansbridge J, Marien S, Neblo MA, Niemeyer S, Setälä M, Slothuus R, Suiter J, Thompson D, Warren ME.

Science. 2019 Mar 15;363(6432):1144-1146. doi: 10.1126/science.aaw2694. No abstract available.

PMID:
30872504
21.

Circulating miRNA Profiling of Women at High Risk for Ovarian Cancer.

Pandey R, Woo HH, Varghese F, Zhou M, Chambers SK.

Transl Oncol. 2019 May;12(5):714-725. doi: 10.1016/j.tranon.2019.01.006. Epub 2019 Mar 9.

22.

Strain Effect on Oxygen Evolution Reaction Activity of Epitaxial NdNiO3 Thin Films.

Wang L, Stoerzinger KA, Chang L, Yin X, Li Y, Tang CS, Jia E, Bowden ME, Yang Z, Abdelsamie A, You L, Guo R, Chen J, Rusydi A, Wang J, Chambers SA, Du Y.

ACS Appl Mater Interfaces. 2019 Apr 3;11(13):12941-12947. doi: 10.1021/acsami.8b21301. Epub 2019 Mar 22.

PMID:
30834739
23.

Evaluation frameworks in health services: An integrative review of use, attributes and elements.

Bradford N, Chambers S, Hudson A, Jauncey-Cooke J, Penny R, Windsor C, Yates P.

J Clin Nurs. 2019 Jul;28(13-14):2486-2498. doi: 10.1111/jocn.14842. Epub 2019 Mar 25. Review.

PMID:
30811715
24.

Health Literacy Among Canadian Men Experiencing Prostate Cancer.

Seaton CL, Oliffe JL, Rice SM, Bottorff JL, Johnson ST, Gordon SJ, Chambers SK.

Health Promot Pract. 2019 Feb 21:1524839919827576. doi: 10.1177/1524839919827576. [Epub ahead of print]

PMID:
30791725
25.

Identifying priorities for cancer caregiver interventions: protocol for a three-round modified Delphi study.

Blaschke SM, Lambert SD, Livingston PM, Aranda S, Boltong A, Schofield P, Chambers SK, Krishnasamy M, Ugalde A.

BMJ Open. 2019 Feb 13;9(2):e024725. doi: 10.1136/bmjopen-2018-024725.

26.

Psychosocial predictors of hope two years after diagnosis of colorectal cancer: Implications for nurse-led hope programmes.

Grealish L, Hyde MK, Legg M, Lazenby M, Aitken JF, Dunn J, Chambers SK.

Eur J Cancer Care (Engl). 2019 May;28(3):e13010. doi: 10.1111/ecc.13010. Epub 2019 Feb 10.

PMID:
30740814
27.

Miniaturisation of high-throughput plasmid DNA library preparation for next-generation sequencing using multifactorial optimisation.

Suckling L, McFarlane C, Sawyer C, Chambers SP, Kitney RI, McClymont DW, Freemont PS.

Synth Syst Biotechnol. 2019 Jan 22;4(1):57-66. doi: 10.1016/j.synbio.2019.01.002. eCollection 2019 Mar.

28.

Five-year outcomes from a randomised controlled trial of a couples-based intervention for men with localised prostate cancer.

Chambers SK, Occhipinti S, Stiller A, Zajdlewicz L, Nielsen L, Wittman D, Oliffe JL, Ralph N, Dunn J.

Psychooncology. 2019 Apr;28(4):775-783. doi: 10.1002/pon.5019. Epub 2019 Feb 18.

PMID:
30716188
29.

A systematic review of cancer caregiver interventions: Appraising the potential for implementation of evidence into practice.

Ugalde A, Gaskin CJ, Rankin NM, Schofield P, Boltong A, Aranda S, Chambers S, Krishnasamy M, Livingston PM.

Psychooncology. 2019 Apr;28(4):687-701. doi: 10.1002/pon.5018. Epub 2019 Mar 7. Review.

PMID:
30716183
30.

A palliative care model and conceptual approach suited to clinical malignant haematology.

Button E, Bolton M, Chan RJ, Chambers S, Butler J, Yates P.

Palliat Med. 2019 May;33(5):483-485. doi: 10.1177/0269216318824489. Epub 2019 Jan 28. No abstract available.

PMID:
30688149
31.

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.

Schumacher FR, Olama AAA, Berndt SI, Benlloch S, Ahmed M, Saunders EJ, Dadaev T, Leongamornlert D, Anokian E, Cieza-Borrella C, Goh C, Brook MN, Sheng X, Fachal L, Dennis J, Tyrer J, Muir K, Lophatananon A, Stevens VL, Gapstur SM, Carter BD, Tangen CM, Goodman PJ, Thompson IM Jr, Batra J, Chambers S, Moya L, Clements J, Horvath L, Tilley W, Risbridger GP, Gronberg H, Aly M, Nordström T, Pharoah P, Pashayan N, Schleutker J, Tammela TLJ, Sipeky C, Auvinen A, Albanes D, Weinstein S, Wolk A, Håkansson N, West CML, Dunning AM, Burnet N, Mucci LA, Giovannucci E, Andriole GL, Cussenot O, Cancel-Tassin G, Koutros S, Beane Freeman LE, Sorensen KD, Orntoft TF, Borre M, Maehle L, Grindedal EM, Neal DE, Donovan JL, Hamdy FC, Martin RM, Travis RC, Key TJ, Hamilton RJ, Fleshner NE, Finelli A, Ingles SA, Stern MC, Rosenstein BS, Kerns SL, Ostrer H, Lu YJ, Zhang HW, Feng N, Mao X, Guo X, Wang G, Sun Z, Giles GG, Southey MC, MacInnis RJ, FitzGerald LM, Kibel AS, Drake BF, Vega A, Gómez-Caamaño A, Szulkin R, Eklund M, Kogevinas M, Llorca J, Castaño-Vinyals G, Penney KL, Stampfer M, Park JY, Sellers TA, Lin HY, Stanford JL, Cybulski C, Wokolorczyk D, Lubinski J, Ostrander EA, Geybels MS, Nordestgaard BG, Nielsen SF, Weischer M, Bisbjerg R, Røder MA, Iversen P, Brenner H, Cuk K, Holleczek B, Maier C, Luedeke M, Schnoeller T, Kim J, Logothetis CJ, John EM, Teixeira MR, Paulo P, Cardoso M, Neuhausen SL, Steele L, Ding YC, De Ruyck K, De Meerleer G, Ost P, Razack A, Lim J, Teo SH, Lin DW, Newcomb LF, Lessel D, Gamulin M, Kulis T, Kaneva R, Usmani N, Singhal S, Slavov C, Mitev V, Parliament M, Claessens F, Joniau S, Van den Broeck T, Larkin S, Townsend PA, Aukim-Hastie C, Gago-Dominguez M, Castelao JE, Martinez ME, Roobol MJ, Jenster G, van Schaik RHN, Menegaux F, Truong T, Koudou YA, Xu J, Khaw KT, Cannon-Albright L, Pandha H, Michael A, Thibodeau SN, McDonnell SK, Schaid DJ, Lindstrom S, Turman C, Ma J, Hunter DJ, Riboli E, Siddiq A, Canzian F, Kolonel LN, Le Marchand L, Hoover RN, Machiela MJ, Cui Z, Kraft P, Amos CI, Conti DV, Easton DF, Wiklund F, Chanock SJ, Henderson BE, Kote-Jarai Z, Haiman CA, Eeles RA; Profile Study; Australian Prostate Cancer BioResource (APCB); IMPACT Study; Canary PASS Investigators; Breast and Prostate Cancer Cohort Consortium (BPC3); PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium; Cancer of the Prostate in Sweden (CAPS); Prostate Cancer Genome-wide Association Study of Uncommon Susceptibility Loci (PEGASUS); Genetic Associations and Mechanisms in Oncology (GAME-ON)/Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium.

Nat Genet. 2019 Feb;51(2):363. doi: 10.1038/s41588-018-0330-6.

PMID:
30622367
32.

Hexafluoroisopropanol-Mediated Domino Reaction for the Synthesis of Thiazolo-androstenones: Potent Anticancer Agents.

Okolo C, Ali MA, Newman M, Chambers SA, Whitt J, Alsharif ZA, Day VW, Alam MA.

ACS Omega. 2018 Dec 31;3(12):17991-18001. doi: 10.1021/acsomega.8b02840. Epub 2018 Dec 21.

33.

The dosing and monitoring of vancomycin: what is the best way forward?

Drennan PG, Begg EJ, Gardiner SJ, Kirkpatrick CMJ, Chambers ST.

Int J Antimicrob Agents. 2019 Apr;53(4):401-407. doi: 10.1016/j.ijantimicag.2018.12.014. Epub 2018 Dec 29. Review.

PMID:
30599240
34.

Comparison of Reproductive Function in Female TgMISIIR-TAg Transgenic and Wildtype C57BL/6 Mice.

Hoyer PB, Rice PF, Howard CC, Koevary JW, Dominguez Cooks JP, Hutchens GV, Chambers SK, Craig ZR, Connolly DC, Barton JK.

Comp Med. 2019 Feb 1;69(1):16-21. doi: 10.30802/AALAS-CM-18-000008. Epub 2018 Dec 27.

PMID:
30591091
35.
36.

Nurse-Led Supportive Care Intervention for Men With Advanced Prostate Cancer.

Ralph N, Chambers S, Pomery A, Oliffe J, Dunn J.

Oncol Nurs Forum. 2019 Jan 13;46(1):92-103. doi: 10.1188/19.ONF.92-103.

PMID:
30547961
37.

Multilevel model with random effects for clustered survival data with multiple failure outcomes.

Tawiah R, Yau KKW, McLachlan GJ, Chambers SK, Ng SK.

Stat Med. 2019 Mar 15;38(6):1036-1055. doi: 10.1002/sim.8041. Epub 2018 Nov 25.

PMID:
30474216
38.

Removing epidural catheters: A guide for nurses.

Sawhney M, Chambers S, Hysi F.

Nursing. 2018 Dec;48(12):47-49. doi: 10.1097/01.NURSE.0000546459.86617.2a.

PMID:
30461711
39.

The Vasoreparative Potential of Endothelial Colony Forming Cells: A Journey Through Pre-clinical Studies.

O'Neill CL, McLoughlin KJ, Chambers SEJ, Guduric-Fuchs J, Stitt AW, Medina RJ.

Front Med (Lausanne). 2018 Oct 16;5:273. doi: 10.3389/fmed.2018.00273. eCollection 2018. Review.

40.
41.

New challenges in psycho-oncology: Economic evaluation of psychosocial services in cancer: Challenges and best practice recommendations.

Tuffaha H, El-Saifi N, Chambers S, Scuffham P.

Psychooncology. 2019 Jan;28(1):3-10. doi: 10.1002/pon.4933. Epub 2018 Nov 15. No abstract available.

PMID:
30440112
42.

BRCA Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma.

Lin KK, Harrell MI, Oza AM, Oaknin A, Ray-Coquard I, Tinker AV, Helman E, Radke MR, Say C, Vo LT, Mann E, Isaacson JD, Maloney L, O'Malley DM, Chambers SK, Kaufmann SH, Scott CL, Konecny GE, Coleman RL, Sun JX, Giordano H, Brenton JD, Harding TC, McNeish IA, Swisher EM.

Cancer Discov. 2019 Feb;9(2):210-219. doi: 10.1158/2159-8290.CD-18-0715. Epub 2018 Nov 13.

PMID:
30425037
43.

Exercise Mode Specificity for Preserving Spine and Hip Bone Mineral Density in Prostate Cancer Patients.

Newton RU, Galvão DA, Spry N, Joseph D, Chambers SK, Gardiner RA, Wall BA, Bolam KA, Taaffe DR.

Med Sci Sports Exerc. 2019 Apr;51(4):607-614. doi: 10.1249/MSS.0000000000001831.

PMID:
30395051
44.

Quality of life and psychological distress in cancer survivors: The role of psycho-social resources for resilience.

Harms CA, Cohen L, Pooley JA, Chambers SK, Galvão DA, Newton RU.

Psychooncology. 2019 Feb;28(2):271-277. doi: 10.1002/pon.4934. Epub 2018 Dec 4.

PMID:
30380589
45.

Human ALKBH3-induced m1A demethylation increases the CSF-1 mRNA stability in breast and ovarian cancer cells.

Woo HH, Chambers SK.

Biochim Biophys Acta Gene Regul Mech. 2019 Jan;1862(1):35-46. doi: 10.1016/j.bbagrm.2018.10.008. Epub 2018 Oct 17.

PMID:
30342176
46.

Conserved thermal performance curves across the geographic range of a gametophytic fern.

Chambers SM, Emery NC.

AoB Plants. 2018 Sep 12;10(5):ply050. doi: 10.1093/aobpla/ply050. eCollection 2018 Oct.

47.

Association Analysis of a Microsatellite Repeat in the TRIB1 Gene With Prostate Cancer Risk, Aggressiveness and Survival.

Moya L, Lai J, Hoffman A, Srinivasan S, Panchadsaram J, Chambers S, Clements JA, Batra J; Australian Prostate Cancer BioResource.

Front Genet. 2018 Oct 4;9:428. doi: 10.3389/fgene.2018.00428. eCollection 2018.

48.

Clinical Indicators That Identify Risk of Deteriorating and Dying in People with a Hematological Malignancy: A Case-Control Study with Multivariable Analysis.

Button E, Gavin NC, Chan RJ, Chambers S, Butler J, Yates P.

J Palliat Med. 2018 Dec;21(12):1729-1740. doi: 10.1089/jpm.2018.0033. Epub 2018 Oct 17.

PMID:
30334690
49.

Biomechanical Material Characterization of Stanford Type-B Dissected Porcine Aortas.

Ahuja A, Noblet JN, Trudnowski T, Patel B, Krieger JF, Chambers S, Kassab GS.

Front Physiol. 2018 Sep 26;9:1317. doi: 10.3389/fphys.2018.01317. eCollection 2018.

50.

Phenotype of vigilin expressing breast cancer cells binding to the 69 nt 3'UTR element in CSF-1R mRNA.

Woo HH, Lee SC, Stoffer JB, Rush D, Chambers SK.

Transl Oncol. 2019 Jan;12(1):106-115. doi: 10.1016/j.tranon.2018.09.012. Epub 2018 Oct 3.

Supplemental Content

Loading ...
Support Center